Latest Breaking News On - Unifortune investment holdings group - Page 1 : comparemela.com

Biopharmaceutical firm Jiangsu Atom Bioscience and Pharmaceutical has bagged 600 million yuan ($82.8 million) in a Series D funding round.

Fund managementUnifortune investment holdings groupAtom bioscienceKaitai capitalFortune capitalKingray capital